Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial
Ngai, Lok Lam, Hanekamp, Diana, Janssen, Fleur, Carbaat-Ham, Jannemieke, Hofland, Maaike A. M. A., Fayed, Mona M. H. E, Kelder, Angèle, Oudshoorn-van Marsbergen, Laura, Scholten, Willemijn J., Snel, Alexander N., Bachas, Costa, Tettero, Jesse M., Breems, Dimitri A., Fischer, Thomas, Gjertsen, Bjørn T., Griškevičius, Laimonas, Juliusson, Gunnar, van de Loosdrecht, Arjan A., Maertens, Johan A., Manz, Markus G., Pabst, Thomas, Passweg, Jakob R., Porkka, Kimmo, Valk, Peter J. M., Gradowska, Patrycja, Löwenberg, Bob, de Leeuw, David C., Janssen, Jeroen J. W. M., Ossenkoppele, Gert J., Cloos, Jacqueline
Published in Blood (25.05.2023)
Published in Blood (25.05.2023)
Get full text
Journal Article